15 August 2026
Latham Advises on MapLight Therapeutics’ US$150 Million Private Placement Financing
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Matt Bush Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Sandy Kugbei Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Jenny Li | Latham & Watkins LLP | Associate | corporate | Not stated |
| Kan Ni | Latham & Watkins LLP | Associate | corporate | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 150m (US$150 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- MapLight Therapeutics, Inc. (Issuer)
institutional and accredited investors (Investor)